Postmenopausal Progestins, MI and Stroke
NCT00005220 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-02-10
Summary
To evaluate the cardiovascular effects of postmenopausal hormone replacement therapy and the suspected beneficial effects on myocardial infarction and stroke.
Conditions
- Cardiovascular Diseases
- Heart Diseases
- Coronary Disease
- Cerebrovascular Accident
- Myocardial Infarction
- Postmenopause
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH - lead OTHER
Eligibility
- Max Age
- 100 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1988-04-30
- Completion
- 1999-01-31
More Related Trials
-
Postmenopausal Hormone Therapy in Unstable Angina
NCT00000601 ·Status: COMPLETED ·Phase: PHASE3
-
Hormone Therapy Effects on CVD Risk Factors
NCT00006313 ·Status: COMPLETED
-
Estrogen, Cytokines and Heart Failure in Women
NCT00041431 ·Status: COMPLETED ·Phase: NA
-
Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women
NCT01633814 ·Status: TERMINATED ·Phase: NA
-
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
NCT04050592 ·Status: UNKNOWN ·Phase: PHASE4
-
Midlife Cholesterol Study
NCT00361075 ·Status: COMPLETED ·Phase: PHASE4
-
Estrogen Replacement and Atherosclerosis (ERA) in Older Women
NCT00000549 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
NCT00005108 ·Status: COMPLETED ·Phase: PHASE2
-
A Longitudinal Study to Identify Mechanisms of Menopause on Cardiovascular Disease Risk
NCT05647876 ·Status: RECRUITING
-
Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function
NCT03112226 ·Status: COMPLETED ·Phase: NA
-
CVD Risk and Health in Postmenopausal Phytoestrogen Users
NCT00000613 ·Status: COMPLETED ·Phase: PHASE2
-
Reduction of Triglycerides in Women on Hormone Replacement Therapy
NCT00023543 ·Status: COMPLETED ·Phase: PHASE2
-
Sex Steroid Hormones and Risk of CHD in Women
NCT00006407 ·Status: COMPLETED
-
Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
NCT00001752 ·Status: COMPLETED ·Phase: PHASE2
-
Influence of Early Menopause on Sympathetic Activation and Cardiovascular Function in Older Women
NCT03692572 ·Status: COMPLETED ·Phase: NA
-
Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters
NCT04453332 ·Status: UNKNOWN ·Phase: NA
-
Menopausal Hormone Therapy And Left Ventricular Function
NCT07242391 ·Status: NOT_YET_RECRUITING
-
Menopause Effects on Vascular Function
NCT03236545 ·Status: COMPLETED ·Phase: NA
-
Sympathetic Vascular Transduction Across the Menopause Transition: Contributing Mechanisms
NCT06787066 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Postmenopausal Estrogen/Progestin Interventions (PEPI)
NCT00000466 ·Status: COMPLETED ·Phase: PHASE3
-
Exercise and Phytoestrogens: Effect on Factors Predisposing to Cardiovascular Disease(CVD) in Postmenopausal Women
NCT01048606 ·Status: COMPLETED ·Phase: PHASE4
-
Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
NCT00000559 ·Status: COMPLETED ·Phase: PHASE3
-
Estrogen Use in Protection From Cognitive Decline
NCT00097058 ·Status: COMPLETED
-
Menopause Related Influences on Leukocyte Distribution, Monocyte Function and Platelet Reactivity
NCT05985447 ·Status: RECRUITING